Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis

Toxicology and Applied Pharmacology

Volumn 164, Issue 3, 2000, Pages 321-329

  Yuan, Cai ^a   Kadiiska, Maria ^a   Achanzar, William E ^a   Mason, Ronald P ^a   Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Cadmium; Chromium

Indexed keywords

CADMIUM; CASPASE 3; CHROMIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; DNA DETERMINATION; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; HAMSTER; NONHUMAN;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034194773     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8921     Document Type: Article

References (49)

1. Abshire M. K., Devor D. E., Diwan B. A., Shaughnessy J. D., Waalkes M. P. In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. Carcinogenesis. 17:1996;1349-1356.
2. Aiyar J., Borges K. M., Floyd R. A., Wetterhahn K. E. Role of chromium(V), glutathione thyol radical and hydroxyl radical intermediates in chromium(VI)-induced DNA damage. Toxicol. Environ. Chem. 22:1989;135-148.
3. Blankenship L. J., Mannning F. C. R., Orenstein J. M., Patierno S. R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol. Appl. Pharmacol. 126:1994;75-83.
4. Blankenship L. J., Carlisle D. L., Wise J. P., Orenstein J. M., Dye L. E., Patierno S. R. Induction of apoptotic cell death by particulare lead chromate: Differential effects of vitamins C and E on genotoxicity and survival. Toxicol. Appl. Pharmacol. 146:1997;270-280.
5. Chai F., Troung-Tran A. Q., Ho L. H., Zalewski P. D. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol. Cell. Biol. 77:1999;272-278.
6. Chen G., Brandon P. E., Shore G. C. Induction of p53-independent apoptosis by hygromycin B: Suppression by Bcl-2 and adenovirus E1B 19-kDa protein. Exp. Cell Res. 221:1995;55-59.
7. Cohen G. M. Caspases: The executioners of apoptosis. Biochem. J. 326:1997;1-16.
8. Coogan T. P., Bare R. M., Waalkes M. P. Cadmium-induced DNA strand damage in cultured liver cells: Reduction in cadmium genotoxicity following zinc pretreatment. Toxicol. Appl. Pharmacol. 113:1992;227-233.
9. Coogan T. P., Bare R. M., Bjornson E. J., Waalkes M. P. Enhanced metallothionein gene expression is associated with protection from cadmium-induced genotoxicity in cultured rat liver cells. J. Toxicol. Environ. Health. 41:1994;233-245.
10. Dally H., Hartwig A. Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis. 18:1997;1021-1026.
11. DeFlora S., Bagnasco M., Serra D., Zanacchi P. Genotoxicity of chromium compounds: A review. Mutat. Res. 238:1990;99-172.
12. Elinder C.-G. Normal values for cadmium in human tissue, blood, and urine in different countries. Friberg L., Elinder C.-G., Kjellström T., Nordberg G. F. Cadmium and Health: A Toxicological and Epidemiological Appraisal. 1985;81-102 CRC Press, Boca Raton.
13. Green D. R. Apoptotic pathways: The roads to ruin. Cell. 94:1998;695-698.
14. Haga A., Nagase H., Kito H., Sato T. Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells. Cancer Biochem. Biophys. 15:1997;275-284.
15. Hissin P. J., Hiff R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
16. Monographs on the Evaluation of the Carcinogenic Risks to Humans. 1990;International Agency for Research on Cancer, Lyon. p. 49-256.
17. Monographs on the Evaluation of the Carcinogenic Risks to Humans. 1993;International Agency for Research on Cancer, Lyon. p. 119-237.
18. Kasai T., Ohguchi K., Nakashima S., Ito Y., Naganawa T., Kondo N., Nozawa Y. Increased activity of oleate-dependent type phospolopase during actinomycin D-induced apoptosis in Jurkat T cells. J. Immunol. 161:1998;6469-6474.
19. LaCasse E. C., Baird S., Korneluk R. G., MacKenzie A. E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:1998;3247-3259.
20. Manning F. C. R., Blankenship L. J., Wise J. P., Xu J., Bridgewater L. C., Patierno S. R. Induction of internucleosomal DNA fragmentation by carcinogenic chromate: Relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. Environ. Health Perspect. 102:1994;159-167.
21. Manning F. C. R., Patierno S. R. Apoptosis: Inhibitor or instigator of carcinogenesis. Cancer Invest. 14:1996;455-465.
22. Misra R. R., Page J. E., Smith G. T., Waalkes M. P., Dipple A. Effect of cadmium exposure on background and anti 5-methylchrysene 1,2-dihydrodiol 3,4-epoxide-induced mutagenesis in the supF gene of pS189 in human Ad293 cells. Chem. Res. Toxicol. 11:1998a;211-216.
23. Misra R. R., Smith G. T., Waalkes M. P. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology. 126:1998b;103-114.
24. Ochi T., Ohsawa M. Participation of active oxygen species in the induction of chromosomal aberrations by cadmium chloride in cultured Chinese hamster cells. Mutat. Res. 143:1985;137-142.
25. Perry D. K., Smyth M. J., Stennicke H. R., Salvesen G. S., Duriez P., Poirier G. G., Hannun Y. A. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. J. Biol. Chem. 272:1997;18530-18533.
26. Shi X. L., Dalal N. S. On the mechanism of the chromate reduction by glutathione: ESR evidence for the glutathionyl radical and an isolable Cr(V) intermediate. Biochem. Biophys. Res. Commun. 156:1988;137-142.
27. Shi X. L., Dalal N. S. Chromium(V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium(VI). Biochem. Biophys. Res. Commun. 163:1989;627-634.
28. Shimada H., Shiao Y.-H., Shibata M.-A., Waalkes M. P. Cadmium suppresses apoptosis induced by chromium. J. Toxicol. Environ. Health. 54:1998;159-168.
29. Sirover M. A., Loeb L. A. Infidelity of DNA synthesis in vitro: Screening for potential metal mutagens and carcinogens. Science. 194:1976;1434-1436.
30. Snow E. T. Metal carcinogenesis: Mechanistic implications. Pharmacol. Ther. 53:1992;31-65.
31. Standeven A. M., Wetterhahn K. E. Chromium(VI) toxicity: Uptake, reduction, and DNA damage. J. Am. Cell. Toxicol. 8:1989;1275-1283.
32. Stearns D. S., Courtney K. D., Giangrande P. H., Phieffer L. S., Wetterhahn K. E. Chromium(VI) reduction by ascorbate: Role of reactive intermediates in DNA damage in vitro. Environ. Health Perspect. 1994a;21-25.
33. Stearns D. S., Kennedy L. J., Courtney K. D., Giangrande P. H., Phieffer L. S., Wetterhahn K. E. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry. 37:1994b;910-919.
34. Stearns D. S., Wetterhahn K. E. Reaction of chromium(VI) with ascorbate produces chromium(V), and carbon-based radicals. Chem. Res. Toxicol. 7:1994;219-230.
35. Stearns D. S., Wetterhahn K. E. Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA. Chem. Res. Toxicol. 10:1997;271-278.
36. Stennicke H. R., Salvesen G. S. Properties of the caspases. Biochim. Biophys. Acta. 1387:1998;17-31.
37. Sugiyama M. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radical Biol. Med. 12:1992;397-407.
38. Sugiyama M. Role of paramagnetic chromium in chromium(VI)-induced damage in cultured mammalian cells. Environ. Health Perspect. 102:1994;31-33.
39. Sugiyama M., Patierno S. R., Cantoni O., Costa M. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells. Mol. Pharmacol. 29:1986;606-613.
40. Sugiyama M., Tsuzuki K., Ogura R. Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate (VI). J. Biol. Chem. 266:1991;3383-3386.
41. Thornberry N. A., Lazebnik Y. Caspases: Enemies within. Science. 281:1998;1312-1316.
42. von Zglinicki T., Edwall C., Ostlund E., Lind B., Nordberg M., Ringertz N. R., Wroblewski J. Very low cadmium concentrations stimulate DNA synthesis and cell growth. J. Cell Sci. 103:1992;1073-1081.
43. Waalkes M. P. Quantitation of metallothionein. Thomas J. A. Methods in Toxicology-Endocrinology. 1996;371-391 Academic Press, San Diego.
44. Waalkes M. P., Coogan T. P., Barter R. A. Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit. Rev. Toxicol. 22:1992;175-201.
45. Waalkes M. P., Misra R. R. Cadmium carcinogenicity and genotoxicity. Chang L. Toxicology of Metals. 1996;231-244 CRC Press, Boca Raton.
46. Waalkes M. P., Poirier L. A. In vitro cadmium-DNA interactions: Cooperativity of cadmium binding and competitive antagonism by calcium, magnesium and zinc. Toxicol. Appl. Pharmacol. 75:1984;539-546.
47. Waalkes M. P., Rehm S., Cherian M. G. Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol. Sci. 54:2000;110-120.
48. Wetterhahn K. E., Hamilton J. W. Molecular basis of hexavalent chromium carcinogenecity: Effect on gene expression. Sci. Total Environ. 86:1989;113-129.
49. Wu C.F., Bishopric N. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem. 272:1997;14860-14866.